Contact
Please use this form to send email to PR contact of this press release:
InSphero and PharmaNest Unveil a Promising Tool for MASH Drug Discovery in a Breakthrough Study
TO:
Rositsa Hadzhipetrova
InSphero AG
+41 44 515 04 90